We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $3.89B
1-Year Est. Return 16.15%
This Fund
S&P 500
This Quarter Est. Return
-4.04%
1 Year Est. Return
+16.15%
3 Year Est. Return
+48.47%
5 Year Est. Return
+55.5%
10 Year Est. Return
+378.36%
AUM
$5.76B
AUM Growth
-$337M
Cap. Flow
-$23.3M
Cap. Flow %
-0.4%
Top 10 Hldgs %
19.29%
Holding
148
New
9
Increased
49
Reduced
77
Closed
8

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$39.1M
2
WOOF
VCA Inc.
WOOF
+$31.9M
3
THS
Treehouse Foods
THS
+$29.1M
4
LSTR icon
Landstar System
LSTR
+$26.8M
5
EPC icon
Edgewell Personal Care
EPC
+$24.3M

Sector Composition

Rank Sector Weight
1 Healthcare 20.75%
2 Financials 16.78%
3 Technology 13.67%
4 Industrials 11.68%
5 Consumer Discretionary 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMED icon
51
Globus Medical
GMED
$10B
$46.7M 0.81%
2,374,180
+530,855
+29% +$10.9M
PH icon
52
Parker-Hannifin
PH
$117B
$46.7M 0.81%
408,965
-7,255
-2% -$855K
CBSH icon
53
Commerce Bancshares
CBSH
$8.39B
$45.9M 0.8%
1,847,523
+143,713
+8% +$3.67M
ANSS
54
DELISTED
Ansys
ANSS
$45.6M 0.79%
602,985
+352,050
+140% +$27.6M
THS
55
DELISTED
Treehouse Foods
THS
$45.2M 0.78%
561,360
-368,380
-40% -$29.1M
WTW icon
56
Willis Towers Watson
WTW
$29.9B
$45.1M 0.78%
410,856
-6,974
-2% -$775K
BGS icon
57
B&G Foods
BGS
$257M
$45.1M 0.78%
1,635,325
+254,300
+18% +$7.5M
PETM
58
DELISTED
PETSMART INC
PETM
$45M 0.78%
641,825
-150,130
-19% -$10.4M
RAVN
59
DELISTED
Raven Industries Inc
RAVN
$44.4M 0.77%
1,817,725
+205,635
+13% +$5.85M
CFR icon
60
Cullen/Frost Bankers
CFR
$10.1B
$43.6M 0.76%
570,070
+420
+0.1% +$33K
ICUI icon
61
ICU Medical
ICUI
$3.9B
$43.3M 0.75%
674,330
-12,390
-2% -$759K
PRO
62
DELISTED
PROS Holdings
PRO
$41M 0.71%
1,626,980
+119,660
+8% +$3.07M
XLNX
63
DELISTED
Xilinx Inc
XLNX
$40.9M 0.71%
964,650
-5,605
-0.6% -$245K
EW icon
64
Edwards Lifesciences
EW
$49.4B
$40.8M 0.71%
2,397,900
-413,580
-15% -$6.53M
PNRA
65
DELISTED
Panera Bread Co
PNRA
$39.5M 0.69%
+242,760
New +$36.6M
CLB icon
66
Core Laboratories
CLB
$563M
$39.1M 0.68%
+267,170
New +$41.2M
MASI
67
DELISTED
Masimo
MASI
$38.2M 0.66%
1,794,025
-32,390
-2% -$739K
RBA icon
68
RB Global
RBA
$15.9B
$38.1M 0.66%
1,701,335
-36,290
-2% -$865K
K
69
DELISTED
Kellanova
K
$38M 0.66%
656,844
-5,730
-0.9% -$346K
ZBH icon
70
Zimmer Biomet
ZBH
$18.8B
$36.9M 0.64%
378,087
+49,558
+15% +$4.87M
INFA
71
DELISTED
INFORMATICA CORP
INFA
$36.7M 0.64%
1,070,590
-18,935
-2% -$630K
ATR icon
72
AptarGroup
ATR
$7.93B
$36.5M 0.63%
602,045
+18,160
+3% +$1.15M
AREX
73
DELISTED
Approach Resources Inc.
AREX
$36.1M 0.63%
2,490,975
-61,450
-2% -$1.15M
NPO icon
74
Enpro
NPO
$6B
$35.7M 0.62%
590,090
-61,585
-9% -$4.19M
LMNX
75
DELISTED
Luminex Corp
LMNX
$35.4M 0.61%
1,812,840
-37,280
-2% -$682K

Similar funds

Champlain Investment Partners's Q3 2014 Portfolio in Review

As of Q3 2014, Champlain Investment Partners held 148 positions worth $5.76B, down 5.5% from $6.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners's Q3 2014 filing shows 9 new, 49 increased, 77 reduced and 8 closed positions. Its largest new stake was Core Laboratories: 267,170 shares worth $39.1M. The largest sale was Intuit, an estimated $39.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Financials and Technology.

  • Champlain Investment Partners's largest Q3 2014 buy was Core Laboratories: 267,170 shares worth $39.1M.
  • Champlain Investment Partners added most to Guidewire Software in Q3 2014, an estimated $31.2M increase.
  • Champlain Investment Partners's biggest Q3 2014 reduction was Intuit, cutting an estimated $39.1M.
  • Champlain Investment Partners fully exited Edgewell Personal Care in Q3 2014, selling an estimated $24.3M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $5.76B portfolio in Q3 2014.
  • Champlain Investment Partners opened 9 new positions and closed 8 in Q3 2014.
  • Champlain Investment Partners's portfolio value fell 5.5% quarter-over-quarter to $5.76B.

Based on Champlain Investment Partners's 13F filing for Q3 2014, filed 14 Nov 2014.